Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update. (2018)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1004
PubMed Identifier: 29392710
Publication URI: http://europepmc.org/abstract/MED/29392710
Type: Journal Article/Review
Volume: 103
Parent Publication: Clinical pharmacology and therapeutics
Issue: 4
ISSN: 0009-9236